These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21928286)

  • 61. Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial.
    Pocock SJ; Mehran R; Clayton TC; Nikolsky E; Parise H; Fahy M; Lansky AJ; Bertrand ME; Lincoff AM; Moses JW; Ohman EM; White HD; Stone GW
    Circulation; 2010 Jan; 121(1):43-51. PubMed ID: 20026777
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diabetes and acute coronary syndromes.
    Roffi M; Eberli FR
    Best Pract Res Clin Endocrinol Metab; 2009 Jun; 23(3):305-16. PubMed ID: 19520305
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Low molecular weight heparins in acute coronary syndrome.
    Creekmore F
    S D J Med; 2000 Jan; 53(1):21-3. PubMed ID: 10652862
    [No Abstract]   [Full Text] [Related]  

  • 64. Trials and tribulations of non-inferiority: the ximelagatran experience.
    Kaul S; Diamond GA; Weintraub WS
    J Am Coll Cardiol; 2005 Dec; 46(11):1986-95. PubMed ID: 16325029
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Issues in the assessment of non-inferiority: perspectives drawn from case studies.
    Burger HU; Beyer U; Abt M
    Pharm Stat; 2011; 10(5):433-9. PubMed ID: 21932300
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.
    Smith JG; Wieloch M; Koul S; Braun OÖ; Lumsden J; Rydell E; Ohman J; Scherstén F; Svensson PJ; van der Pals J
    EuroIntervention; 2012 Oct; 8(6):672-8. PubMed ID: 23086784
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Safety of new oral anticoagulants with dual antiplatelet therapy in patients with acute coronary syndromes.
    Tsu LV; Dager WE
    Ann Pharmacother; 2013 Apr; 47(4):573-7. PubMed ID: 23548645
    [TBL] [Abstract][Full Text] [Related]  

  • 68. One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trial.
    Schulz S; Kastrati A; Ferenc M; Massberg S; Birkmeier KA; Laugwitz KL; Kufner S; Gick M; Dommasch M; Schühlen H; Schömig A; Berger PB; Mehilli J; Neumann FJ;
    EuroIntervention; 2013 Aug; 9(4):430-6. PubMed ID: 23455033
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A note on the determination of non-inferiority margins with application in oncology clinical trials.
    Yu B; Yang H; Sabin A
    Contemp Clin Trials Commun; 2019 Dec; 16():100454. PubMed ID: 31650074
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
    White HD; Chew DP; Hoekstra JW; Miller CD; Pollack CV; Feit F; Lincoff AM; Bertrand M; Pocock S; Ware J; Ohman EM; Mehran R; Stone GW
    J Am Coll Cardiol; 2008 May; 51(18):1734-41. PubMed ID: 18452778
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?
    Huber K; Bates ER; Valgimigli M; Wallentin L; Kristensen SD; Anderson JL; Lopez Sendon JL; Tubaro M; Granger CB; Bode C; Ohman EM; Steg PG
    Am Heart J; 2014 Nov; 168(5):611-21. PubMed ID: 25440788
    [TBL] [Abstract][Full Text] [Related]  

  • 72. TACT method for non-inferiority testing in active controlled trials.
    Wang SJ; Hung HM
    Stat Med; 2003 Jan; 22(2):227-38. PubMed ID: 12520559
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Non-inferiority versus superiority drug claims: the (not so) subtle distinction.
    Ganju J; Rom D
    Trials; 2017 Jun; 18(1):278. PubMed ID: 28619049
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation.
    Quartagno M; Walker AS; Babiker AG; Turner RM; Parmar MKB; Copas A; White IR
    Trials; 2020 Feb; 21(1):145. PubMed ID: 32029000
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Design of non-inferiority randomized trials using the difference in restricted mean survival times.
    Weir IR; Trinquart L
    Clin Trials; 2018 Oct; 15(5):499-508. PubMed ID: 30074407
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Non-inferiority test for a continuous variable with a flexible margin in an active controlled trial: an application to the "Stratall ANRS 12110 / ESTHER" trial.
    Sandie AB; Molinari N; Wanjoya A; Kouanfack C; Laurent C; Tchatchueng-Mbougua JB
    Trials; 2022 Mar; 23(1):202. PubMed ID: 35248123
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Some essential considerations in the design and conduct of non-inferiority trials.
    Fleming TR; Odem-Davis K; Rothmann MD; Li Shen Y
    Clin Trials; 2011 Aug; 8(4):432-9. PubMed ID: 21835862
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bayesian approach to non-inferiority trials for normal means.
    Gamalo MA; Wu R; Tiwari RC
    Stat Methods Med Res; 2016 Feb; 25(1):221-40. PubMed ID: 22619277
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A Bayesian non-inferiority approach using experts' margin elicitation - application to the monitoring of safety events.
    Aupiais C; Alberti C; Schmitz T; Baud O; Ursino M; Zohar S
    BMC Med Res Methodol; 2019 Sep; 19(1):187. PubMed ID: 31533631
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evidence-based sizing of non-inferiority trials using decision models.
    Lansdorp-Vogelaar I; Jagsi R; Jayasekera J; Stout NK; Mitchell SA; Feuer EJ
    BMC Med Res Methodol; 2019 Jan; 19(1):3. PubMed ID: 30612554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.